NCT07050303Completed
The Effect of a Mobile Application Based on the Social Cognitive Learning Theory on Medication Adherence and Hypertension Self-Efficacy in Patients With Hypertension: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 3 Jul 2025
Brief summary (registry, in English)
In this study, a mobile application designed based on the Social Cognitive Theory was evaluated in middle-aged individuals with hypertension: H1(a): A mobile application based on the Social Cognitive Theory affects medication adherence self-efficacy levels in patients with hypertension. H0(a): A mobile application based on the Social Cognitive Theory does not affect medication adherence self-efficacy levels in patients with hypertension. H1(b): A mobile application based on the Social Cognitive Theory affects hypertension self-efficacy levels in patients with hypertension. H0(b): A mobile application based on the Social Cognitive Theory does not affect hypertension self-efficacy levels in patients with hypertension. H1(c): A mobile application based on the Social Cognitive Theory affects systolic and diastolic blood pressure levels in patients with hypertension. H0(c): A mobile application based on the Social Cognitive Theory does not affect systolic and diastolic blood pressure levels in patients with hypertension. Participants were asked to download and use the hypertension monitoring application designed by the researcher on their phones for a period of three months. A pre-test was administered through face-to-face interviews before installing the application. After using the application for three months, a post-test was conducted using the same scales through face-to-face interviews. For the control group, the same pre-test was administered through face-to-face interviews without using the application. After three months, a post-test was again conducted via face-to-face interviews. The researchers compared the data of the participants with those of the control group.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 86 (actual)
- First submitted
- 29 Jan 2025
- Start date
- Dec 2024
- Primary completion date
- Mar 2025
- Lead sponsor
- Gozde Aygun
- Diseases
- High blood pressure
- NCT number
- NCT07050303
What you commit to
- Study type: Interventional
- Participants enrolled: 86
- From Dec 2024 to the primary completion date, Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Research Inclusion Criteria:
- Diagnosed with hypertension (for at least 6 months).
- Currently using antihypertensive medication.
- Voluntarily agrees to participate in the research.
- Aged between 40-64 years (Turkish Society of Hypertension and Renal Diseases, 2012; TURKSTAT, 2022).
- Literate.
- No mental or communication-impairing issues.
- Not pregnant or a breastfeeding mother.
- Able to use a smartphone with an Android operating system.
- No additional comorbid diseases (e.g., cancer, diabetes mellitus).
- Has a semi-automatic upper-arm blood pressure monitor at home.
- Research Exclusion Criteria:
- Experiencing issues with internet access or mobile application usage.
- Voluntarily withdraws from the study during the research process.
- Uses an different operating system than Android operating system.
Age in the registry: 41 years to 64 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aydın Adnan Menderes University Coordinator of this site? Confirm its status | Aydin | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.